Promotive effects of the dietary organic germanium poly- trans-[(2-carboxyethyl) germasesquioxane] (Ge-132) on the secretion and antioxidative activity of bile in rodents

Journal of Health Science

Volumn 56, Issue 1, 2010, Pages 72-80

  Nakamura, Takashi ^a,b   Nagura, Taizo ^c   Akiba, Mitsuo ^b   Sato, Katsuyuki ^b   Tokuji, Yoshihiko ^d   Ohnishi, Masao ^a,d   Osada, Kyoichi ^a,b,e  

^a IWATE UNIVERSITY   (Japan)

^b Asai Germanium Research Institute Co Ltd   (Japan)

^c Nippon Beet Sugar Mfg Co Ltd   (Japan)

^d OBIHIRO UNIVERSITY OF AGRICULTURE AND VETERINARY MEDICINE   (Japan)

^e MEIJI UNIVERSITY   (Japan)

Author keywords

Bile acid; Bilirubin; Organic germanium; Poly trans (2 carboxyethyl) germasesquioxane ; Uridine diphosphate glucuronosyltransferase 1a1

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; AMINO ACID N ACYLTRANSFERASE; BILE ACID; BILE PIGMENT; BILIRUBIN; BILIRUBIN GLUCURONIDE; CARBOXYETHYLGERMANIUM SESQUIOXIDE; COENZYME A; GLUCURONOSYLTRANSFERASE 1A1; MESSENGER RNA; STERCOBILIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BILE; BILE SECRETION; BODY WEIGHT; CECUM; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATIONAL STUDY; DIET; DRUG EFFECT; DRUG MECHANISM; FECES; FECES COLOR; INTESTINE; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; RODENT; SAMPLE; WISTAR RAT;

RATTUS; RATTUS NORVEGICUS; RODENTIA;

EID: 76349096017     PISSN: 13449702     EISSN: 13475207     Source Type: Journal    
DOI: 10.1248/jhs.56.72     Document Type: Article

References (27)

1. Tsutsui, M., Kakimoto, N., Axtell, D. D., Oikawa, H. and Asai, K. (1976) Crystal structure of "carboxyethylgermanium sesquioxide." J. Am. Chem. Soc., 98, 8287-8289.
2. Sugiya, Y., Sakamaki, S., Sugita, T., Abo, Y. and Satoh, H. (1986) Subacute oral toxicity of carboxyethylgermanium sesquioxide (Ge-132) in rats. Ouyou Yakuri, 31, 1181-1190 (in Japanese).
3. Miyao, K. and Tanaka, N. (1988) Carboxyethylgermanium sesquioxide and related organogermanium compounds. Drugs of the Future, 13, 441-453.
4. Kumano, N., Ishikawa, T., Koinumaru, S., Kikumoto, T., Suzuki, S., Nakai, Y. and Konno, K. (1985) Antitumor effect of the organogermanium compound Ge-132 on the Lewis Lung Carcinoma (3LL) in C57BL/6 (B6) mice. Tohoku J. Exp. Med., 146, 97-104.
5. Aso, H., Suzuki, F., Ebina, T. and Ishida, N. (1989) Antiviral activity of caboxyethylgermanium sesquioxide (Ge-132) in mice infected with influenza virus. J. Biol. Response Mod., 8, 180-189.
6. Fujii, A., Kuboyama, N., Yamane, J., Nakao, S. and Furukawa, Y. (1993) Effect of organic germanium compound (Ge-132) on experimental osteoporosis in rats. Gen. Pharmacol., 24, 1527-1532.
7. Arimori, S., Yoshida, M. and Ichimura, K. (1990) Improved rheumatoid arthritis case with Ge-132 administration evaluated by clinically and immunologically using two-color flow cytometry. Jpn. J. Clin. Immun., 13, 80-86 (in Japanese).
8. Aso, H., Suzuki, F., Yamaguchi, T., Hayashi, Y., Ebina, T. and Ishida, N. (1985) Induction of interferon and activation of NK cells and macrophages in mice by oral administration of Ge-132, an organic germanium compound. Microbiol. Immunol., 29, 65-74.
9. Sanai, T., Okuda, S., Onoyam, K., Oochi, N., Takaichi, S., Mizuhira, U. and Fujishima, M. (1991) Chronic tubulointerstitial changes induced by germanium dioxide in comparison with carboxyethylgermanium sesquioxide. Kidney Int., 40, 882-890.
10. Kagoshima, M., Ohnishi, T., Suguro, N. and Tomizawa, S. (1986) Metabolic fate of 2-carboxygermanium sesquioxide (1) oral administration. Ouyou Yakuri, 32, 71-79 (in Japanese).
11. Boron, W. and Boulpaep, E. (2009) Medical Physiology: A Cellular and Molecular Approach, 2nd edition, Saunders Elsevier, Philadelphia, pp. 988-991.
12. Stocker, R., Yamamoto, Y., McDonagh, A., Glazer, A. and Ames, B. (1987) Bilirubin is antioxidant of possible physiological importance. Science, 235, 1043-1046.
13. Yamaguchi, T., Hashizume, T., Tanaka, M., Nakayama, M., Sugimoto, A., Ikeda, S., Nakajima, H. and Horio, F. (1997) Bilirubin oxidation provoked by endotoxin treatment is suppressed by feeding ascorbic acid in a rat mutant unable to synthesize ascorbic acid. Eur. J. Biochem., 245, 233-240.
14. Folch, J., Lees, M. and Stanley, G. H. S. (1957) A simple method for the isolation and purification of total lipids from animal tissue. J. Biol. Chem., 225, 497-509.
15. Marion, J., Sheltawy, J. and Losowsky, M. S. (1975) Determination of faecal bile acids by an enzymic method. Clin. Chim. Acta, 64, 127-132.
16. Ishikawa, F., Takayama, H., Matsumoto, K., Ito, M., Osanami, O., Ideguchi, Y., Kikuchi, H. and Watanuki, M. (1995) Effects of b1-4 linked Galactooligosaccharides on human fecal microflora. Bifidus, 9, 5-18 (in Japanese).
17. Moscowitz, A., Weimer, M., Lightner, D. A., Petryka, Z. J., Davis, E. and Watson, C. J. (1970) The in vitro conversion of bile pigments to the urobilinoids by a rat clostridia species as compared with the human fecal flora. Biochem. Med., 4, 149-164.
18. Spivak, W., DiVenuto, D. and Yuey, W. (1987) Non-enzymic hydrolysis of bilirubin mono- and diglucuronide to unconjigated bilirubin in model and native bile systems (Potential role in the formation of gallstones). Biochem. J., 242, 323-329.
19. Shintani, T., Takahashi, N., Fushiki, T., Kotera, J. and Sugimoto, E. (1995) Recognition system for dietary fatty acids in the rat small intestine. Biosci. Biotechnol. Biochem., 59, 1428-1432.
20. Takada, H., Hirooka, T., Hiramatsu, Y. and Yamamoto, M. (1982) Effect of β-glucuronidase inhibitor on azoxymethane-induced colonic carcinogenesis in rats. Cancer Res., 42, 331-334.
21. Mastromarino, A., Reddy, B. and Wynder, E. L. (1976) Metabolic epidemiology of colon cancer: enzymic activity of fecal flora. Am. J. Clin. Nutr., 29, 1455-1460.
22. Tenhunen, R., Marver, H. S. and Schmid, R. (1969) Microsomal heme oxygenase. Characterization of the enzyme. J. Biol. Chem., 244, 6388-6394.
23. Nakamura, T., Sato, K., Akiba, M. and Ohnishi, M. (2006) Urobilinogen, as a bile pigment metabolite, has an antioxidant function. Journal of Oleo Science, 55, 191-197.
24. Yamaguchi, T., Shioji, I., Sugimoto, A., Komoda, Y. and Nakajima, H. (1994) Chemical structure of a new family of bile pigments from human urine. J. Biochem., 116, 298-303.
25. 4-induced hepatic damage in mice. Ouyou Yakuri, 27, 1119-1131 (in Japanese).
26. Dulik, D. M. and Fenselau, C. (1988) Use of immobilized enzymes in drug metabolism studies. FASEB J., 2, 2235-2240.
27. McDonagh, A. F., Lightner, D. A., Nogales, D. F. and Norona, W. S. (2001) Biliary excretion of a stretched bilirubin in UGT1A1-deficient (Gunn) and Mrp2-deficient (TR-) rats. FEBS Lett., 506, 211-215.